Localization of transforming growth factors β1 and β2 and epidermal growth factor in IgA nephropathy

Scandinavian Journal of Urology and Nephrology

Volumn 33, Issue 4, 1999, Pages 243-247

  Taniguchi, Yoshihiko ^a   Yorioka, Noriaki ^a   Masaki, Takao ^a   Asakimori, Yukiteru ^a   Yamashita, Kazuomi ^a   Yamakido, Michio ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Epidermal growth factor; IgA nephropathy; Transforming growth factor 1; Transforming growth factor 2

Indexed keywords

ENZYME ANTIBODY; EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TISSUE DISTRIBUTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032859001     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655999750015853     Document Type: Article

References (23)

1. Kujubu DA, Fine LG. Physiology and cell biology update: Polypeptide growth factors and their relation to renal disease. Am J Kidney Dis 1989; 14: 61-73.
2. Humes HD, Nakamura T, Cieslinski DA, Miller D, Emmons RV, Border WA. Role of proteoglycans and cytoskeleton in the effects of TGF-β1 on renal proximal tubule cells. Kidney Int 1993; 43: 575-84.
3. Nouwen EJ, De Broe ME. EGF and TGF-α in the human kidney: identification of octopal cells in the collecting duct. Kidney Int 1994; 45: 1510-21.
4. Ong ACM, Fine LG. Loss of glomerular function and tubulointerstitial fibrosis: cause or effect? Kidney Int 1994; 45; 345-51.
5. Wardle N. Glomerulosclerosis: the final pathway is clarified, but can we deal with the triggers? Nephron 1996; 73: 1-7.
6. Taniguchi Y, Yorioka N, Oda H, Yamakido M. Platelet-derived growth factor, interleukin (IL)-1β, IL-6, IL-6R and tumor necrosis factor-α in IgA nephropathy. Nephron 1996; 74: 652-60.
7. Abe S, Amagasaki Y, Iyori S, Konishi K, Kato E, Sakaguchi H. Significance of tubulointerstitial lesions in biopsy specimens of glomerulonephritic patients. Am J Nephrol 1989; 9: 30-7.
8. Bertoluci MC, Schmid H, Lachat JJ, Coimbra TM. Transforming growth factor-beta in the development of rat diabetic nephropathy. Nephron 1996; 74: 189-96.
9. Galla JH. IgA nephropathy. Kidney Int 1995; 47: 377-87.
10. MacKey K, Kondaiah P, Danielpour D, Austin III HA, Brown PD. Expression of transforming growth factor-β1 and β2 in rat glomeruli. Kidney Int 1990; 38: 1095-100.
11. Davies M, Martin J, Thomas GJ, Lovett DH. Proteinases and glomerular matrix turnover. Kidney Int 1992; 41: 671-8.
12. Razzaque MS, Harada T, Taguchi T. Significance of increased accumulation of type VI collagen and transforming growth factor β1 in tubulointerstitial damage in hypertensive nephrosclerosis: an immunohistochemical study. J Int Med Res 1996; 24: 199-208.
13. Jones CL. Matrix degradation in renal disease. Nephrology 1996; 2: 13-23.
14. Marinides GN, Suchard SJ, Mookerjee BK. Role of thrombospondin in mesangial cell growth: possible existence of an autocrine feedback growth circuit. Kidney Int 1994; 46: 350-7.
15. Eddy AA, Giachelli CM, McCulloch L, Liu E. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 1995; 47: 1546-57.
16. Lonnemann G, Shapiro L, Engler-Blum G, Müller GA, Koch KM, Dinarello CA. Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts. Kidney Int 1995; 47: 837-44.
17. Schulze-Lohoff E, Schagerl S, Ogilvie A, Sterzel RB. Extracellular ATP augments mesangial cell growth induced by multiple growth factors. Nephrol Dial Transplant 1995; 10: 2027-34.
18. Truong LD, Pindur J, Foster S, Majesky M, Suki WN. Tenascin expression in nephrogenesis and in normal or pathologic glomerulus morphologic features and functional implications. Nephron 1996; 72: 499-506.
19. Niemir ZI, Stein H, Noronha IL, Krüger C, Andrassy K, Ritz E, et al. PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis. Kidney Int 1995; 48: 1530-41.
20. Taniguchi Y, Yorioka N, Masaki T, Yamashita K, Ito T, Ueda C, et al. Role of transforming growth factor-β1 in glomerulonephritis. Int Med Res 1997; 25: 71-80.
21. Phillips PA, Grant SL, Davidson AF, Risvanis J, Stephenson J, Gow CB. Epidermal growth factor antagonizes vasopressin in vivo and in vitro. Kidney Int 1994; 45: 1028-36.
22. Norman J, Tsau YK, Bacay A, Fine LG. Epidermal growth factor accelerates functional recovery from ischaemic acute tubular necrosis in the rat: role of the epidermal growth factor receptor. Clin Sci 1990; 78: 445-50.
23. Gesualdo L, Di Paolo S, Calabro A, Milani S, Maiorano E, Ranieri E, et al. Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunohistochemical and in situ hybridization study. Kidney Int 1996; 49: 656-65.